TORRANCE, Calif.--(BUSINESS WIRE)--Celprogen Inc., a leader in the Stem Cell Research and Therapeutics industry committed to providing high quality stem cell technologies for regenerative medicine, today announced that they have developed a novel Xeno-Free Serum Substitute [XFS2] cell culture media product for human cell culture systems. XFS2 product (Catalog number MX7777-15) can be utilized for culturing stem cells, progenitor cells, induced pluripotent cells and primary human cells for clinical application. The product can also be utilized for culturing cancer stem cells, circulating tumor cells and differentiated parental tumor cells for basic science research in Oncology.
Help employers find you! Check out all the jobs and post your resume.
